Earnings History Data for Metacrine, Inc. (MTCR) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Metacrine, Inc.

Metacrine Inc. is a clinical-stage biopharmaceutical company. It is focused on discovering and developing therapies for patients with liver and gastrointestinal diseases. The company's program includes MET409 and MET642 which are in clinical trial. Metacrine Inc. is based in San Diego, United States.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
09-08-2022 AH 4:05 PM ET
(Aug 9)
MTCR Metacrine 21.00 -0.15 -0.40 0.00 Metacrine reports Q2 results
[8/9/2022 5:31 PM]
0.5001 0.01 
(2.06%)
0.51 0.02 
(4.08%)
0.35 - 4.12 655,433 360,000 7,237
30-03-2022 AH After the close
(Mar 30)
MTCR Metacrine, Inc. 24.77 -0.44 -0.68 0.00 Metacrine reports Q4 results
[3/30/2022 5:36 PM]
0.5999 0.01 
(2.35%)
0.59 0.0 
(0.67%)
0.39 - 6.59 2,684,450 3,160,000 126,070
13-05-2021 AH After the close
(May 13)
MTCR Metacrine, Inc. 92.00 -0.57 -0.52 0.00 Metacrine reports Q1 results
[5/13/2021 5:31 PM]
3.35 -0.02 
(-0.59%)
3.37 0.0 
(0.00%)
3.30 - 16.19 38,020 90,000 194
18-03-2021 PM 6:30 AM ET
(Mar 18)
MTCR Metacrine, Inc. 213.62 N/A -0.37 0.00 Metacrine reports Q4 results
[3/18/2021 6:55 AM]
7.79 -0.25 
(-3.11%)
0.0 0.0 
(0.00%)
7.64 - 16.19 69,238 40,000 0